Camber Capital Management LLC, Ten Percent Owner at Sequenom, holds 5.45M shares in ZimVie Inc (Ticker: ZIMV), holds 0.00 shares in Amag Pharmaceuticals (Ticker: AMAG), holds 24.11M shares in Protalix (Ticker: PLX). Most recently, Camber Capital Management LLC Sold ― shares of ZimVie Inc on Aug 06, 2024 for an estimated value of 9.30M.
What was Camber Capital Management LLC’s latest transaction?
Camber Capital Management LLC latest transaction was an Informative Sell of $9.30M.
What was Camber Capital Management LLC's most profitable transaction?
Camber Capital Management LLC’s most profitable transaction was an Informative Buy of CSII stock on February 25, 2016. The return on the trade was 242.00%.
What is Camber Capital Management LLC's role in Sequenom?
Camber Capital Management LLC's role in Sequenom is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.